bpc 157 arginate oral bpc-157 vs acetate Drew Timmermans, ND, RMSK BPC-157 (Arginate Salt) - Xcel

Systemic inflammation that has no single injury source, the kind that shows up as widespread musculoskeletal pain, persistent fatigue, and poor recovery from training, is typically where BPC-157 works best as part of a stack rather than in isolation

Dihexa is not FDA-approved and is sold only by research peptide suppliers

Primary Handling Editor: Christoph Schmitt, in collaboration with the Nature Metabolism team

**BPC-157, a synthetic gastric pentadecapeptide studied primarily in animal models for tissue repair, gut healing, and anti-inflammatory effects, remains unapproved by the FDA as a finished drug with only limited small-scale human data available.** It was placed in Category 2 in 2023 due to concerns over immunogenicity, peptide impurities, and insufficient safety information for compounding under Section 503A